Form 4 for SPRB SPRUCE BIOSCIENCES, INC.
Accepted 2023-01-05 00:00:00 ET · period of report 2022-12-30 · accession 0001209191-23-002152 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-05 | 2022-12-30 | SPRB | Szwarcberg Javier B. | CEO, Dir | A - Grant | $0.93 | +14.7K | 14.7K | New | +$13.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-30 | A | A | 14,705 | $0.93 | 14,705 | D | — | — | (F1) Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code. |